-
David Nevins Interviews Dr. Matthew Frieman, Associate Professor, University of Maryland School of Medicine
Post on 3/7/21
-
BioCryst Reports Fourth Quarter and Full Year 2020 Financial Results
Post on 2/25/21
-
Chimerix Reports Fourth Quarter and Year End 2020 Financial Results and Provides Operational Update
Post on 2/25/21
-
Novan Reports Full Year 2020 Financial Results and Provides Corporate Update
Post on 2/25/21
-
United Therapeutics Corporation Reports Fourth Quarter And Full Year 2020 Financial Results
Post on 2/24/21
-
PRA Health Sciences Reports Fourth Quarter and Full Year 2020 Results
Post on 2/24/21
-
IQVIA Prices of Offering of Senior Notes
Post on 2/18/21
-
Safest States During COVID-19 – Updated WalletHub Study
Post on 2/18/21
-
Syneos Health Reports Fourth Quarter and Full Year 2020 Results
Post on 2/18/21
-
Pattern Health Secures $1.5M
Post on 2/16/21
-
IQVIA Offers of Senior Notes
Post on 2/16/21
-
Bioventus Prices of IPO
Post on 2/11/21
-
2021's States with the Best & Worst Dental Health - WalletHub Study
Post on 2/10/21
-
2021’s Healthiest & Unhealthiest Cities in America – WalletHub Study
Post on 2/8/21
-
Ambu Expands Single-Use Endoscopy Contracts with Two U.S. Group Purchasing Organizations
Post on 2/6/21
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Post on 2/2/21
-
Chambless Johnston Discusses Comorbid Diagnosis: Addiction and Other Mental Health Issues and What it Means for Treatment
Post on 1/27/21
-
States that Have the Fewest COVID-19 Restrictions – Updated WalletHub Study
Post on 1/26/21
-
Chimerix Closes Public Offering of Common Stock
Post on 1/25/21
-
Chimerix Prices Public Offering of Common Stock
Post on 1/20/21
-
Chimerix Proposes $75,000,000 Public Offering of Common Stock
Post on 1/19/21
-
Spine Pain Center Announces Grand Opening of New Location
Post on 1/7/21
-
Syneos Health Acquires Synteract
Post on 12/10/20
-
Cities That Need the Most Initial Vaccinations Against COVID-19 – WalletHub Study
Post on 12/10/20
-
Royalty Pharma Acquires Royalty Interest in ORLADEYO and BCX9930 From BioCryst Pharmaceuticals
Post on 12/7/20
Charlotte Raleigh
